|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
|
|---|---|---|---|---|
| Assets | ||||
| Cash | ||||
| Other receivables | ||||
| Total assets | ||||
| Liability and equity | ||||
| Total liabilities | ||||
| Equity | ||||
| Common shares, $0.001 par value per share, 100,000 shares authorized, 40 shares issued and outstanding at June 30, 2026 and December 31, 2025 | ||||
| Additional paid-in capital | ||||
| Accumulated earnings | ||||
| Total equity | ||||
| Total liabilities and equity |
Loading...
